Teewinot Capital Advisers’s Lam Research LRCX Stock Holding History

Teewinot Capital Advisers’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-601,195	Closed	-$80.5M	–	35
2025 Q3	$80.5M	Sell	601,195 -262,268	-30%	-$27.8M	6.26%	7
2025 Q2	$84M	Buy	863,463 +366,774	+74%	+$29.1M	6.91%	6
2025 Q1	$36.1M	Buy	+496,689	New	+$39.1M	3.69%	14

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Teewinot Capital Advisers's LRCX Position: Q4 2025 in Review

Teewinot Capital Advisers sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 601,195 shares — an estimated $80.5M sold.

Teewinot Capital Advisers first reported a position in LRCX in Q1 2025 and held it in 3 quarters. The position peaked at $84M in Q2 2025. 2,393 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Teewinot Capital Advisers reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Teewinot Capital Advisers sold 601,195 Lam Research shares in Q4 2025, an estimated $80.5M.
Teewinot Capital Advisers first reported a position in Lam Research in Q1 2025 and held it in 3 quarters.
Teewinot Capital Advisers's Lam Research position peaked at $84M in Q2 2025.
2,393 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Teewinot Capital Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.